Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
18 oct. 2017 08h01 HE
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Navigators to Announce its Third Quarter 2017 Financial Results on Thursday, November 2, 2017
06 oct. 2017 16h10 HE
|
The Navigators Group, Inc.
STAMFORD, Conn., Oct. 06, 2017 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) will announce its third quarter financial results after the close of regular stock market hours on...
Navigators Estimates Natural Catastrophe Losses for Third Quarter
05 oct. 2017 16h01 HE
|
The Navigators Group, Inc.
STAMFORD, Conn., Oct. 05, 2017 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) today announced that its estimated financial impact from natural catastrophes in the third quarter will...
Lantronix to Report Fiscal 2017 Third Quarter Results on April 27, 2017
13 avr. 2017 08h15 HE
|
Lantronix Inc.
IRVINE, Calif., April 13, 2017 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ:LTRX), a global provider of secure data access and management solutions for Internet of Things (IoT) and information...
Vital Therapies Announces Third Quarter Financial Results
03 nov. 2016 16h01 HE
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2016 Financial Results on November 7, 2016
31 oct. 2016 16h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
ATN Reports Third Quarter and Nine Month 2016 Results
26 oct. 2016 17h02 HE
|
ATN International, Inc.
Third Quarter 2016 Financial Highlights: Revenues: $138.8 millionAdjusted EBITDA1: $46.4 millionOperating income: $22.1 millionNet income attributable to ATN’s stockholders: $7.2 million, or $0.44...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
25 oct. 2016 16h01 HE
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
ATN International Sets Date To Report Third Quarter 2016 Results
17 oct. 2016 14h36 HE
|
ATN International, Inc.
BEVERLY, Mass., Oct. 17, 2016 (GLOBE NEWSWIRE) -- ATN (NASDAQ:ATNI) announced today that it will report results for the third quarter ended September 30, 2016 on Wednesday, October 26, 2016, at...
ATN Reports Third Quarter and Nine Month 2015 Results
28 oct. 2015 17h05 HE
|
ATN International, Inc.
Third Quarter 2015 Highlights: Revenues of $96.8 millionAdjusted EBITDA1 of $39.7 millionOperating income of $22.5 million included $2.5 million of transaction-related costsNet income...